BridgeBio Pharma, Inc. (BBIO)
81.07
-0.43
(-0.53%)
USD |
NASDAQ |
Aug 24, 16:00
80.04
-1.03
(-1.27%)
After-Hours: 20:00
BridgeBio Pharma Price : 81.07 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 80.98 | 81.68 | 80.16 | 81.07 | 1.113M |
| Aug 21, 2026 | 82.89 | 83.37 | 81.36 | 81.50 | 1.744M |
| Aug 20, 2026 | 83.51 | 84.36 | 82.63 | 82.94 | 2.031M |
| Aug 19, 2026 | 84.22 | 85.65 | 83.25 | 83.95 | 3.285M |
| Aug 18, 2026 | 80.54 | 83.95 | 80.10 | 82.98 | 2.718M |
| Aug 17, 2026 | 79.15 | 80.42 | 78.12 | 79.89 | 2.796M |
| Aug 14, 2026 | 80.14 | 80.56 | 78.60 | 79.86 | 3.094M |
| Aug 13, 2026 | 84.77 | 84.77 | 80.78 | 81.21 | 1.280M |
| Aug 12, 2026 | 83.47 | 84.99 | 82.82 | 83.84 | 2.794M |
| Aug 11, 2026 | 87.02 | 89.49 | 83.35 | 83.70 | 3.082M |
| Aug 10, 2026 | 83.45 | 86.00 | 83.45 | 84.67 | 2.943M |
| Aug 07, 2026 | 83.72 | 85.03 | 82.24 | 84.48 | 2.148M |
| Aug 06, 2026 | 81.50 | 84.66 | 81.50 | 82.80 | 1.221M |
| Aug 05, 2026 | 82.86 | 83.57 | 81.46 | 81.99 | 2.425M |
| Aug 04, 2026 | 80.80 | 82.32 | 80.04 | 82.07 | 1.703M |
| Aug 03, 2026 | 81.23 | 81.23 | 78.82 | 79.96 | 1.367M |
| Jul 31, 2026 | 82.38 | 82.40 | 79.46 | 80.09 | 2.133M |
| Jul 30, 2026 | 80.06 | 82.41 | 79.60 | 82.14 | 2.516M |
| Jul 29, 2026 | 85.49 | 85.78 | 83.35 | 83.54 | 2.401M |
| Jul 28, 2026 | 84.24 | 85.66 | 83.02 | 85.55 | 2.180M |
| Jul 27, 2026 | 84.10 | 86.32 | 83.98 | 84.12 | 2.187M |
| Jul 24, 2026 | 83.46 | 85.30 | 82.74 | 84.02 | 2.058M |
| Jul 23, 2026 | 82.40 | 83.53 | 81.77 | 82.93 | 1.531M |
| Jul 22, 2026 | 82.47 | 82.88 | 81.02 | 82.66 | 1.569M |
| Jul 21, 2026 | 80.80 | 82.61 | 80.76 | 82.45 | 1.389M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 236.01 |
| Ionis Pharmaceuticals, Inc. | 62.04 |
| Pfizer Inc. | 27.97 |
| Vertex Pharmaceuticals, Inc. | 547.59 |
| BioMarin Pharmaceutical, Inc. | 65.07 |
Price Related Metrics
| PS Ratio | 22.06 |
| Earnings Yield | -4.40% |
| Market Cap | 15.83B |